| Precursor chemicals | Laboratory apparatus |
| Methylamine | Condensers |
| Ethylamine | Distilling apparatus |
| D-Lysergic acid | Vacuum dryers |
| Ergotamine tartrate | Three-necked flasks, two-necked flasks, single-necked flasks |
| Diethyl malonate | Distilling flasks |
| Malonic acid | Tableting machines |
| Ethyl malonate | Encapsulating machines |
| Barbituric acid | Filter funnels, Buchner funnels, and separatory funnels |
| Piperidine | Flasks: Erlenmeyer, two-neck, single-neck, round-bottom, thermometer, and filtering |
| N-acetyl anthranilic acid | Soxhlet extractors |
| Pyrrolidine | Transformers |
| Phenylacetic acid | Flask heaters |
| Anthranilic acid | Heating mantles |
| Ephedrine | Adapter tubes |
| Pseudoephedrine |
|
| Norpseudoephedrine |
|
| Phenylpropanolamine |
|
| Controlled substance analog* |
|
Notes: * = a substance that is substantially similar in chemical structure to that of a controlled substance or has central nervous system activity that is substantially similar to or greater than that of a controlled substance. The MOU does not establish any minimum quantities of precursor chemicals nor size of glassware or equipment. Prescription and nonprescription medicinal formulations are exempted.